These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 8587444)
1. Involvement of endothelin-1 in deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy. Matsumura Y; Fujita K; Miyazaki Y; Takaoka M; Morimoto S J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S456-8. PubMed ID: 8587444 [TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy. Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S5-8. PubMed ID: 8587458 [TBL] [Abstract][Full Text] [Related]
3. Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats. Fujita K; Matsumura Y; Miyazaki Y; Takaoka M; Morimoto S Jpn J Pharmacol; 1996 Apr; 70(4):313-9. PubMed ID: 8774759 [TBL] [Abstract][Full Text] [Related]
4. Endothelin: role in hypertension. Schiffrin EL Biol Res; 1998; 31(3):199-208. PubMed ID: 9830507 [TBL] [Abstract][Full Text] [Related]
5. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension. Fujita K; Matsumura Y; Kita S; Miyazaki Y; Hisaki K; Takaoka M; Morimoto S Br J Pharmacol; 1995 Mar; 114(5):925-30. PubMed ID: 7780646 [TBL] [Abstract][Full Text] [Related]
6. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats. Fujita K; Matsumura Y; Miyazaki Y; Hashimoto N; Takaoka M; Morimoto S Life Sci; 1996; 58(1):PL1-7. PubMed ID: 8628104 [TBL] [Abstract][Full Text] [Related]
7. A proteasome inhibitor prevents vascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats. Takaoka M; Ohkita M; Itoh M; Kobayashi Y; Okamoto H; Matsumura Y Clin Exp Pharmacol Physiol; 2001; 28(5-6):466-8. PubMed ID: 11380524 [TBL] [Abstract][Full Text] [Related]
9. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension. Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138 [TBL] [Abstract][Full Text] [Related]
10. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats. Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506 [TBL] [Abstract][Full Text] [Related]
11. In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Day R; Larivière R; Schiffrin EL Am J Hypertens; 1995 Mar; 8(3):294-300. PubMed ID: 7794580 [TBL] [Abstract][Full Text] [Related]
12. Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats. Itoh H; Nakao K; Mukoyama M; Yamada T; Hosoda K; Shirakami G; Morii N; Sugawara A; Saito Y; Shiono S J Clin Invest; 1989 Jul; 84(1):145-54. PubMed ID: 2544622 [TBL] [Abstract][Full Text] [Related]
13. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. Schiffrin EL; Turgeon A; Deng LY Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550 [TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats. Ishii R; Tagawa T; Ishida T; Naruse T Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146 [TBL] [Abstract][Full Text] [Related]
15. Prolonged endothelin blockade prevents hypertension and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Stasch JP; Hirth-Dietrich C; Frobel K; Wegner M Am J Hypertens; 1995 Nov; 8(11):1128-34. PubMed ID: 8554737 [TBL] [Abstract][Full Text] [Related]
16. Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats. Schiffrin EL; Lariviere R; Li JS; Sventek P; Touyz RM Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S188-90. PubMed ID: 9072349 [TBL] [Abstract][Full Text] [Related]
17. Effect of endothelin-3 on blood pressure in conscious spontaneously hypertensive [SHR] and DOCA-salt hypertensive rats. Januszewicz A; Loń S; Lapiński M; Styś A J Physiol Pharmacol; 1994 Mar; 45(1):105-19. PubMed ID: 8043901 [TBL] [Abstract][Full Text] [Related]
18. Renal AT1 receptor: computerized quantification in spontaneously hypertensive rats and DOCA-salt rats. Asano N; Ogura T; Mimura Y; Otsuka F; Kishida M; Hashimoto M; Yamauchi T; Makino H Res Commun Mol Pathol Pharmacol; 1998 May; 100(2):171-80. PubMed ID: 9667071 [TBL] [Abstract][Full Text] [Related]
19. Role of endothelin and vasopressin in DOCA-salt hypertension. Yu M; Gopalakrishnan V; McNeill JR Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238 [TBL] [Abstract][Full Text] [Related]
20. Endothelin ET(B) receptor-mediated action on systemic and renal hemodynamics and urine formation in deoxycorticosterone acetate-salt-induced hypertensive rats. Hashimoto N; Kuro T; Fujita K; Azuma S; Matsumura Y Biol Pharm Bull; 1998 Aug; 21(8):800-4. PubMed ID: 9743245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]